Form 8-K
8-K — Health In Tech, Inc.
Accession: 0001213900-26-089249
Filed: 2026-08-13
Period: 2026-08-13
CIK: 0002019505
SIC: 6411 (INSURANCE AGENTS BROKERS & SERVICES)
Item: Regulation FD Disclosure
Item: Financial Statements and Exhibits
Documents
8-K — ea0301984-8k_health.htm (Primary)
EX-99.1 — TRANSCRIPT (ea030198401ex99-1.htm)
GRAPHIC (ea030198401_ex99-1img1.jpg)
XML — IDEA: XBRL DOCUMENT (R1.htm)
8-K — CURRENT REPORT
8-K (Primary)
Filename: ea0301984-8k_health.htm · Sequence: 1
false
0002019505
0002019505
2026-08-13
2026-08-13
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 OR 15(d) of The Securities
Exchange Act of 1934
August 13, 2026
Date of Report (Date of earliest event reported)
Health In Tech, Inc.
(Exact name of registrant as specified in its charter)
Nevada
001-42449
87-3545722
(State or other jurisdiction
of incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
701 S. Colorado Ave, Suite 1
Stuart, FL
34994
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including
area code: (888) 373-0333
N/A
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b)
of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Class A Common Stock, $0.001 par value per share
HIT
The Nasdaq Stock Market LLC (Nasdaq Capital Market)
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities
Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☒
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01. Regulation FD Disclosure.
Earnings Call Script
On August 13, 2026, Health
In Tech, Inc., a Nevada corporation (the “Company”), hosted a conference call to discuss its financial and operating results
for the quarter ended Jun 30, 2026. A transcript of the conference call is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
As previously disclosed, a replay of the entire conference call is available for on-demand listening through approximately 90 days after
the date hereof via the Investor Relations page of the Company’s website at https://healthintech.investorroom.com.
The information set forth
in Item 7.01 of this Current Report on Form 8-K and in the attached Exhibit 99.1 are deemed to be “furnished” and shall not
be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), or otherwise subject to the liabilities of that Section. The information set forth in Item 7.01 of this Current Report on
Form 8-K, including Exhibit 99.1, shall not be deemed incorporated by reference into any filing under the Exchange Act or the Securities
Act of 1933, as amended, regardless of any general incorporation language in such filing.
Forward-Looking Statements
Certain statements in this
Current Report on Form 8-K or the accompanying exhibits are forward-looking statements for purposes of the safe harbor provisions under
the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about Health
In Tech’s possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive
position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms
such as “may,” “will,” “should,” “design,” “target,” “aim,” “hope,”
“expect,” “could,” “intend,” “plan,” “anticipate,” “estimate,”
“believe,” “continue,” “predict,” “project,” “potential,” “goal,”
or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to Health In Tech’s
future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause Health In Tech’s
actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance
or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements
because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond Health In Tech’s
control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Some of the risks and
uncertainties, although not all risks and uncertainties, that could cause the Company’s actual results to differ materially from
those presented in its forward-looking statements are set forth in the “Risk Factors” section in the Company’s Annual
Report on Form 10-K, its Quarterly Reports on Form 10-Q, and all of its other filings with the U.S. Securities and Exchange Commission,
as such risks, uncertainties and other important factors may be updated from time to time in the Company’s subsequent reports. Any
forward-looking statement reflects Health In Tech’s current views with respect to future events and is subject to these and other
risks, uncertainties and assumptions relating to Health In Tech’s operations, results of operations, growth strategy and liquidity.
Health In Tech undertakes no obligation to update any forward-looking statements, except as required by law.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits:
Exhibit No.
Description
99.1
Transcript.
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
1
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: August 13, 2026
HEALTH IN TECH, INC.
By:
/s/ Tim Johnson
Name:
Tim Johnson
Title:
Chief Executive Officer
2
EX-99.1 — TRANSCRIPT
EX-99.1
Filename: ea030198401ex99-1.htm · Sequence: 2
Exhibit 99.1
Q2 2026 Earnings Conference Call
August 13, 2026
5:00 PM ET
Presenter Dial-In (US/Canada Toll Free): 1-866-250-8117
International Dial-In: 1-412-317-6011
Presenters are asked to please connect a minimum
of 15 minutes prior to the conference start time. When the speakers are connected, the conference specialist will do a brief sound check
for your line. You will also be asked to review the following items: verify conference title, the first speaker’s name and pronunciations
of other speakers’ names, Q&A restrictions or priority questioners, who will read the safe harbor language, any questions regarding
special services or requests.
Q&A
Link: https://qa6.choruscall.com/contexweb/ViewQA/loginSortQA.htm
View Q&A Conference Code: 10210903
The link below provides access to the Q&A
admin portal. There is no need to log in unless you would like to message the host directly during the call or view who has raised their
hand to ask a question.
Operator
Good day, ladies and gentlemen. Thank you for
standing by, and welcome to the Health In Tech second quarter 2026 earnings conference call. Currently, all participants are in listen-only
mode. Later, we will conduct a question-and-answer session, and instructions will follow at that time. As a reminder, we are recording
today’s call. If you have any objections, you may disconnect at this time.
Now I will turn the call over to Lori Babcock,
Chief of Staff for the company. Ms. Babcock, please proceed.
Lori Babcock – Chief of Staff
Thank you, operator, and hello, everyone. Welcome
to Health In Tech’s second quarter 2026 earnings conference call. Joining us today are Mr. Tim Johnson, Chief Executive Officer,
and Ms. Julia Qian, Chief Financial Officer. Full details of our results can be found in our earnings press release and in our related
Form 10-Q, recently filed with the SEC. These documents will be available on our Investor Relations website at healthintech.investorroom.com.
As a reminder, today’s call is being recorded, and a replay will be available on our IR website as well.
Before we continue, please note that today’s
discussion includes forward-looking statements made pursuant to the Safe Harbor provisions of the U.S. Private Securities Litigation
Reform Act of 1995. These statements are based on information available as of today and involve risks, uncertainties, and assumptions
that could cause actual results to differ materially from those expressed or implied, including those discussed in our quarterly report
on Form 10-Q for the period ended June 30, 2026, filed with the SEC. Please review the forward-looking and cautionary statements section
at the end of our earnings release for various factors that could cause actual results to differ materially from forward-looking statements
made during our call today.
Except as expressly required by the federal securities
laws, we undertake no obligation to update and expressly disclaim the obligation to update these forward-looking statements to reflect
events or circumstances after the date of this call or to reflect new information or the occurrence of unanticipated events. We may also
refer to certain financial measures not in accordance with generally accepted accounting principles, such as adjusted EBITDA, for comparison
purposes only. Our GAAP results and reconciliations of GAAP to non-GAAP measures can be found in our earnings press release.
With that, I will now turn the call over to our
CEO, Mr. Tim Johnson.
Tim Johnson – CEO
Thank you, Lori, and good afternoon, everyone.
We appreciate you joining us today.
Before I get into the quarter, I want to take
some time to reiterate, because I think it’s important, for everyone on this call to understand exactly what kind of company we
are building toward.
Health In Tech is a young and a very dynamic
company. We are still early in our journey. But we operate with a business model, a technology foundation, and a market opportunity in
front of us that we believe will continue to drive enterprise value for the company. That is not about next quarter. It is a statement
about the architecture and foundation of this business, and I want to spend my time today explaining why we believe that, because I think
it matters more than any single quarter’s revenue print.
Let’s start with the macro picture.
We are living through the most consequential
technology shift in enterprise software in a generation. Every industry that has historically run on manual, paper-based, relationship-only
processes is being rebuilt around artificial intelligence, and insurance – and self-funded health insurance specifically –
is one of the most underdeveloped, most opaque corners of that broader economy. As we’ve discussed before, self-funded health plans
are estimated to generate around 20-30% savings for business employers through actively managing vendors and customizing its health plans.
It represents nearly a one trillion-dollar self-funded insurance market, distributed through more than one million insurance brokers
nationwide, and today our platform works with 933 of them. That is a fraction of one percent of the addressable distribution universe.
Most AI implementations you read about in the news today are bolted onto legacy systems, built to automate a single task, or wrapped
around a call center. That is not what we have built. We have built a marketplace that is connecting brokers, third-party administrators
and carriers into one secured, AI enabled health insurance platform that is efficient, transparent, and ultimately, reduces costs through
removing frictions. That distinction matters enormously as this market modernizes.
I want to be direct about something: not every
company that says “AI” has actually built something differentiated. A lot of what passes for AI in financial services and
insurance today is a thin layer of automation on top of decades-old infrastructure. What we have built at Health In Tech goes well beyond
that. Our platform doesn’t just speed up a form – it ingests census data, parses experience data automatically, enables the
carrier to build its specific underwriting criteria in-system in real time, and returns a bindable, execution-ready quote in a fraction
of the time it takes using legacy tools. That is a fundamentally different value proposition than what brokers have had access to historically,
and it is a fundamentally different value proposition than what most of our would-be competitors have brought to market to date.
I want to spend time here to talk about our Chief
Technology Officer, Sri Rajagopalan, and the engineering team he has built. Sri spent the majority of his career at SAP and IBM –
two of the largest enterprise software companies in the world – leading enterprise architecture and large-scale platform engineering
for global, mission-critical systems. That is exactly the caliber of technical leadership a company like ours needs as we scale from
a promising platform serving hundreds of brokers to critical infrastructure serving thousands of brokers, larger carriers, and larger
employer groups. Under Sri’s leadership, and through our partnership with Ciklum, an Amazon Web Services Advanced Tier Service
Partner, we have spent this year upgrading the front- and back-end architecture of our platform – consolidating quoting, underwriting,
administration, and analytics into a single, unified environment, and building the data infrastructure that will allow us to layer in
increasingly sophisticated AI capabilities without having to re-architect the platform every time we do it. That is the kind of investment
that doesn’t always show up in a single quarter’s income statement, but it is exactly the kind of investment that determines
whether a platform company can actually scale, or whether it hits a ceiling. We do not intend to hit a ceiling.
I am also proud of what this has translated into
for our distribution partners in practice. In the second quarter, we grew our distribution partner network to 933 brokers, third-party
administrators and agencies, up nearly 20% from a year ago. We rolled out a significant platform update that included enhanced Census
Insights, expanded large-group quoting functionality, automated experience data parsing, AI-driven risk insights, and direct broker-to-underwriter
messaging inside the platform itself. Brokers are telling us, in real time, that this is changing how they work. That adoption curve
is the leading indicator for everything else we’re going to talk about today.
2
Now, I want to spend a meaningful amount of time
on why we are changing how we talk about our business, because I think this is the single most important thing for investors to understand
about where Health In Tech is today.
For the last several quarters, we have talked
about Health In Tech primarily as a revenue growth story – and to be fair, we earned that framing. But a revenue growth story,
on its own, undersells what is actually happening inside this business, and frankly, we believe it paints a limited picture quarter to
quarter, because of how GAAP revenue recognition interacts with the way our policies are actually sold and onboarded.
Here is the reality: this is not a company that
should be judged quarter-by-quarter on a single reported revenue line. This is a young, still-evolving platform business, continuing
to establish itself in the small-cap world, with a business model that generates contractually locked-in revenue well ahead of when that
revenue actually gets recognized on our income statement. When we sell a policy, we don’t recognize that revenue all at once –
it gets recognized ratably, month by month, over the 12- or 36-month life of that policy. That means the revenue we report in any given
quarter is really a lagging, indicator of the underlying momentum of the business. In our view, the leading indicator – the one
that actually tells you where this Company is headed – is what we’ve contracted, what we’ve sold, and what is already
locked in and simply waiting to be recognized.
That is precisely what happened this quarter,
and I want to explain it plainly rather than let anyone read more into a single number than they should. During the second quarter we
onboarded a new carrier partner, and as part of that onboarding, the effective dates of a number of policy placements shifted into subsequent
quarters. That timing shift is the primary reason our reported GAAP revenue for the second quarter came in at $8.1 million, down from
$9.3 million a year ago. I want to be unambiguous: this was not a demand problem, it was not a churn problem, and it was not a platform
problem. It was a timing factor tied to onboarding a new carrier onto our platform – the very kind of carrier expansion that, as
we discussed last quarter, is core to our long-term growth strategy, because more carriers means more underwriting choice, better pricing
outcomes for employers, and higher conversion for our brokers.
This is exactly why we believe Contracted Revenue
and Pipeline Revenue are the metrics that actually tell you what’s happening inside Health In Tech – and it’s why you
should expect us to lead with these metrics from this point forward. Contracted Revenue – meaning revenue that is contractually
committed under active policies and that simply has not yet been recognized under GAAP – totaled $32.3 million for the first half
of 2026,. Beyond what’s already contracted, our Pipeline Revenue – policies currently in quoting or binding status, plus
policies contracted since quarter-end – stood at $66.3 million as of July 31this year
Julia is going to walk you through the details
in a moment, because I want to spend more of our time today on where this business is going, not re-hashing a single quarter.
Let me talk about what’s coming, because
this is where I think the growth story really comes into focus.
We made a genuine proof point this quarter on
our Three-Year Rate Stabilization Program – we contractually secured our first employer group under that program, taking it from
concept to a live, bound plan. This is an important milestone as we advance toward the program’s anticipated launch in the capital
markets. The program is designed to provide budgetary certainties for healthcare costs – often the second largest expense in the
P&L for many corporations. For large enterprises, particularly governmental agencies and municipalities, multi-year budget certainty
is well received compared to the potential for unpredictable annual healthcare cost hikes. We are currently engaged with several high-profile
governmental organizations evaluating participation, and we expect to provide additional updates in the coming months.
We also remain on track to officially launch
HitRix in the second half of this year. This platform is genuinely new — because HitRix is not an incremental feature update. We
believe it is the first true marketplace built for the large group self-funded stop-loss market, which is a segment defined by claims-data
complexity, multiple managing general underwriters and carriers competing for business, and a manual, fragmented process that has not
meaningfully changed in decades.
To put this in context, eDIYBS, our existing
platform, serves the small group market, where the process is very different. The small groups market itself is highly concentrated with
only a handful of stop-loss carriers. HitRix, conversely, is purpose-built for large groups, generally 100 individuals and above, where
the underwriting process is fundamentally different and the marketplace opportunity is much larger.
3
HitRix introduces several first-of-their-kind
capabilities to this market: proprietary data parsing that transforms hours of broker preparation into minutes; a competitive marketplace
that lets brokers efficiently reach an unlimited number of underwriters simultaneously; real-time comparison and analytics tools that
no other platform in the market offers today; and a “Buy Now” function that can compress what has historically been a weeks-long
negotiation into a same-day close.
It is a marketplace distinct from anything we
have brought to this platform to date, and we believe it opens up a meaningful new growth avenue for this Company. We expect and look
forward to sharing more at launch.
I also want to set the stage for how we intend
to fund this next phase of growth.
I want to close my remarks the way I opened them.
Health In Tech is a fast growing young company. We have a technology foundation built by a world-class engineering team, a business model
that generates real, contractually locked-in revenue well ahead of recognition, a distribution network that is growing nearly 20% year
over year, and a market opportunity measured in the hundreds of billions of dollars where our current penetration remains below one-tenth
of one percent. We believe the combination of these four key things should help continuously drive the enterprise value of the company
That is the story we are building, and I could not be more excited about where this is headed.
Before Julia walks through the financials, let
me give you a bit more color on how our distribution engine performed this quarter.
To put a finer point on the partner number I
mentioned earlier: we ended the second quarter with 933 distribution partners – brokers, third-party administrators and agencies
– up 19.9% from 778 a year ago. That growth came the same way it has all year: through a capital-light, partner-driven model, where
our in-house team focuses on onboarding and activating partners rather than selling directly into employer accounts. That’s what
allows us to keep growing our distribution footprint without a linear increase in fixed cost.
The carrier onboarding that affected the timing
of some of this quarter’s revenue is a good example of the trade-off we’re willing to make. Short-term, it shifted some policy
effective dates into later quarters. Long-term, it gives our brokers more underwriting choice on the same employer groups, which we believe
improves close rates and strengthens retention. We would make that trade every time.
We continue to see this industry as relationship-driven
today, but structurally underserved by technology, and that is the gap we intend to keep closing – through direct broker engagement,
industry conferences, and a platform that keeps getting easier for brokers to use and harder for them to walk away from.
With that, I’ll now turn it over to Julia.
Julia Qian – CFO
Thank you, Tim, and good afternoon, everyone.
I’m going to keep my remarks focused and
brief, because Tim has already walked you through certain considerations around this quarter’s numbers. I want to use my time simply
to walk through the figures themselves, through the lens of the metrics we introduced last quarter – contracted revenue and platform
placed plan value – because those are the numbers that we believe most accurately reflect the underlying health of this business.
Contracted Revenue – meaning revenue that is contractually committed under active policies and that simply has not yet been recognized
under GAAP – totaled $32.3 million for the first half of 2026. Of that, $17.3 million was already recognized as GAAP revenue in
the first half of 2026, with the remaining $14.0 million expected in the second half of 2026 and $1.0 million in 2027,. Beyond what’s
already contracted, our Pipeline Revenue – policies currently in quoting or binding status, plus policies contracted since quarter-end
– stood at $66.3 million as of July 31, of which $1.9 million was contracted, the remaining $64.4 million with an expected conversion
rate of 15% to 40%. With five more months remaining in 2026, the expanded sales team will continue to expand its Pipeline revenue through
adding more brokers, third-party administrators and our distribution channels. Together, these are the numbers I would encourage you
to assess for future revenue visibility, and they underpin our decision to reaffirm full-year 2026 revenue guidance of $45 million to
$50 million. That is real, forward revenue visibility extending well into next year, and it is a very different picture than what a single
quarter’s top-line print can tell you.
4
Now turning to Platform Placed Plan Value, or
PPPV, which represents the aggregate contractual value of the self-funded stop-loss plans placed through our platform – including
premium, claim funding and administrative fees – measured over each plan’s full contractual term. I want to be clear that
PPPV is a measure of platform transaction volume, not an indication of our own revenue or take rate.
On reported GAAP revenue, total revenue for the
second quarter was $8.1 million, down 13.5% from $9.3 million in the second quarter of 2025. As Tim explained, this decrease reflects
the timing of a new carrier onboarding that shifted certain policy effective dates into future periods, not a change in underlying demand.
The onboarding of a new carrier and certain related portfolio transfers between carriers were designed to provide greater options and
flexibility to employers, and as a result, the number of accounts receivable days, or AR days, in the first half of this year, was 55
days versus 20 days in the first half of 2025, which is not uncommon to us. We have ample experience and a track record of managing AR
days – for example, there were 42 AR days in 2023, 29 in 2024, and 14 AR days in 2025.
For the first six months of 2026, total revenue
was $16.8 million, compared to $17.3 million for the first six months of 2025. Turning to profitability, adjusted EBITDA was negative
$1.3 million for the quarter and negative $2.6 million for the first half of 2026, compared to positive $1.6 million and $2.8 million,
respectively, in the prior year periods. Net loss for the quarter was $2.5 million, or $(0.04) per diluted share, compared to net income
of $0.6 million, or $0.01 per diluted share, in the prior year period, and Net loss was $4.1 million for the first half of 2026, or $(0.07)
per diluted share, compared to net income of $1.1 million, or $0.02 per diluted share, in the prior year period. This reflects our continued
planned investment in sales, marketing and technology to support long-term growth, consistent with what we described entering this year.
Our total operating expenses for the quarter
were $7.4 million, compared to $5.6 million same period last year. Sales and marketing expenses were $2.2 million, compared to $1.2 million
same period last year, as we continue to invest in expanding our distribution footprint. General and administrative expenses were $4.3
million, compared to $3.8 million same period last year, and research and development expenses were $0.9 million and we capitalized
$0.8 million of software development costs, compared to $0.6 million and $0.9 million, respectively, [same period last
year, reflecting continued investment in our technology platform under Sri’s leadership.
Turning to our balance sheet, we ended
the quarter with $6.5 million in cash and cash equivalents and $11.8 million in working capital, compared to $8.1 million in cash and
cash equivalents and $9.5 million in working capital a year ago. Operating cash used improved to $2.9 million in the second quarter,
compared to $3.3 million in the first quarter, reflecting continued discipline in working capital management. Total assets at quarter
end were $29.6 million, and total stockholders’ equity was $19.6 million, compared to $22.2 million and $16.4 million, respectively,
same period last year. Our balance sheet remains healthy and appropriately positioned to execute on our products
developments plan.
In summary, this was a quarter of continued,
deliberate investment. The GAAP revenue number reflects a timing shift, not a change in the trajectory of the business, and we believe
contracted revenue and platform placed plan value are the clearest windows into where this Company is actually headed.
With that, I’ll now turn it back to Lori.
Thank you Julia and Tim for these prepared remarks,
and now we would like to open the call up to our community for any questions they might have.
Operator
Question-and-Answer Session
Operator
Thank you. Seeing no more questions in the queue,
let me turn the call back to Mr. Johnson for closing remarks.
5
Tim Johnson– CEO
Thank you, operator, and thank you all for joining
us today.
Before we close, I want to leave you with this.
Health In Tech was not built to be a marginally better version of how self-funded insurance has always been sold. We built this Company
to replace a process that has been slow, opaque, and expensive for employers for decades — and we are doing exactly that, every
single day, at scale. Every quote our platform generates in minutes instead of weeks, every carrier we add to widen competitive pricing,
every plan we streamline into a single, transparent framework — that is real money staying in the pockets of the businesses and
employees who trust us with their healthcare plans. Collectively, our platform has already helped employers avoid hundreds of thousands
of dollars in unnecessary costs, and as we scale into larger employer groups and expand our carrier network, that number grows with us.
This team knows how to execute. We have grown
this business profitably, we have built and shipped technology most companies our size couldn’t attempt, and we have done it with
capital discipline every step of the way. We are not asking you to take our growth story on faith — we are asking you to look at
what we have already built, and to measure us against what we do next.
We are just getting started. Thank you all for
your continued trust and partnership, and we look forward to updating you again next quarter.
With that, I’ll now turn it back to Lori
for our closing statement.
Lori Babcock - CoS
This is all the time we have for today. This
concludes the Heath in Tech Q2 2026 investor earnings conference call.
We encourage our community to continue to reach
out to us and we can answer any questions that you have individually. You can send your questions into us at ir@healthintech.com
We would like to thank all our listeners, shareholders,
analysts, and others who have taken the time to listen to our earnings call. We urge you to refer to our latest SEC filings for any information
that you need. This call will be available from our website in the investors section, and you will find the link there.
To be alerted to news, events, and other information in
a timely manner, we recommend following us on all our social media channels, sign up to our newsletter, and explore our
website at www.healthintech.com.
Thank you everyone participating and listening
to the call today.
Operator
Thank you all again. This concludes the call.
You may now disconnect.
Operator
Thank you all again. This concludes the call.
You may now disconnect.
6
GRAPHIC
GRAPHIC
Filename: ea030198401_ex99-1img1.jpg · Sequence: 3
Binary file (7719 bytes)
Download ea030198401_ex99-1img1.jpg
XML — IDEA: XBRL DOCUMENT
XML
Filename: R1.htm · Sequence: 8
v3.26.1
Cover
Aug. 13, 2026
Cover [Abstract]
Document Type
8-K
Amendment Flag
false
Document Period End Date
Aug. 13, 2026
Entity File Number
001-42449
Entity Registrant Name
Health In Tech, Inc.
Entity Central Index Key
0002019505
Entity Tax Identification Number
87-3545722
Entity Incorporation, State or Country Code
NV
Entity Address, Address Line One
701 S. Colorado Ave
Entity Address, Address Line Two
Suite 1
Entity Address, City or Town
Stuart
Entity Address, State or Province
FL
Entity Address, Postal Zip Code
34994
City Area Code
888
Local Phone Number
373-0333
Written Communications
false
Soliciting Material
false
Pre-commencement Tender Offer
false
Pre-commencement Issuer Tender Offer
false
Title of 12(b) Security
Class A Common Stock, $0.001 par value per share
Trading Symbol
HIT
Security Exchange Name
NASDAQ
Entity Emerging Growth Company
true
Elected Not To Use the Extended Transition Period
false
X
- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details
Name:
dei_AmendmentFlag
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Area code of city
+ References
No definition available.
+ Details
Name:
dei_CityAreaCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Cover page.
+ References
No definition available.
+ Details
Name:
dei_CoverAbstract
Namespace Prefix:
dei_
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
No definition available.
+ Details
Name:
dei_DocumentPeriodEndDate
Namespace Prefix:
dei_
Data Type:
xbrli:dateItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details
Name:
dei_DocumentType
Namespace Prefix:
dei_
Data Type:
dei:submissionTypeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 1 such as Attn, Building Name, Street Name
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine1
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 2 such as Street or Suite number
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine2
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the City or Town
+ References
No definition available.
+ Details
Name:
dei_EntityAddressCityOrTown
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Code for the postal or zip code
+ References
No definition available.
+ Details
Name:
dei_EntityAddressPostalZipCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the state or province.
+ References
No definition available.
+ Details
Name:
dei_EntityAddressStateOrProvince
Namespace Prefix:
dei_
Data Type:
dei:stateOrProvinceItemType
Balance Type:
na
Period Type:
duration
X
- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityCentralIndexKey
Namespace Prefix:
dei_
Data Type:
dei:centralIndexKeyItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityEmergingGrowthCompany
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 7A
-Section B
-Subsection 2
+ Details
Name:
dei_EntityExTransitionPeriod
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
No definition available.
+ Details
Name:
dei_EntityFileNumber
Namespace Prefix:
dei_
Data Type:
dei:fileNumberItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Two-character EDGAR code representing the state or country of incorporation.
+ References
No definition available.
+ Details
Name:
dei_EntityIncorporationStateCountryCode
Namespace Prefix:
dei_
Data Type:
dei:edgarStateCountryItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityRegistrantName
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityTaxIdentificationNumber
Namespace Prefix:
dei_
Data Type:
dei:employerIdItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Local phone number for entity.
+ References
No definition available.
+ Details
Name:
dei_LocalPhoneNumber
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 13e
-Subsection 4c
+ Details
Name:
dei_PreCommencementIssuerTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14d
-Subsection 2b
+ Details
Name:
dei_PreCommencementTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Title of a 12(b) registered security.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b
+ Details
Name:
dei_Security12bTitle
Namespace Prefix:
dei_
Data Type:
dei:securityTitleItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the Exchange on which a security is registered.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection d1-1
+ Details
Name:
dei_SecurityExchangeName
Namespace Prefix:
dei_
Data Type:
dei:edgarExchangeCodeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14a
-Subsection 12
+ Details
Name:
dei_SolicitingMaterial
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details
Name:
dei_TradingSymbol
Namespace Prefix:
dei_
Data Type:
dei:tradingSymbolItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 425
+ Details
Name:
dei_WrittenCommunications
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration